Utpal Koppikar Net Worth & Insider Trades
Utpal Koppikar - Chief Financial Officer, Atara Biotherapeutics, Inc
What is Utpal Koppikar's Net Worth?
The current estimated net worth of Atara Biotherapeutics, Inc's Chief Financial Officer, Utpal Koppikar, is estimated to be about $887.17K . Utpal Koppikar owns about 181,978 units of Atara Biotherapeutics, Inc common stock. In the last 5 years at Atara Biotherapeutics, Inc, Utpal Koppikar has sold an estimated value of $705.32K worth.
What is Utpal Koppikar's Past Insider Trading?
Utpal Koppikar's largest purchase order was 2,000 units , worth over $73.6K on September 11, 2018. Utpal Koppikar's largest sale order was 5,820 units , worth over $81.83K on June 9, 2021. In total, Utpal Koppikar has made about 27 transactions over 5 years of their time at Atara Biotherapeutics, Inc. Utpal Koppikar usually trades in March, with the busiest year in 2021. The most recent transaction was a sale order of 6,871 units , worth over $24.92K on March 6, 2023.
Utpal Koppikar
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What was Utpal Koppikar's Salary in 2020?
As Chief Financial Officer of Atara Biotherapeutics, Inc, Utpal Koppikar has a total base salary of $460,947 . Utpal Koppikar received compensation valued at about $2,137,953 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of a bonus of $187,032 , stock awards of $885,431 , option awards of $597,073 , and other compensation of $7,470 .
What is Utpal Koppikar's' Mailing Address?
- Mailing address is C/o Atara Biotherapeutics, Inc. 611 Gateway Blvd, Suite 900 South San Francisco CA 94080 CA
Atara Biotherapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Pascal Touchon, D.V.M. | 2020 | $654,857 | $422,500 | $2,235,600 | $1,959,208 | $13,662 | $5,285,827 |
Pascal Touchon, D.V.M. | 2019 | $319,327 | $334,791 | $2,861,712 | $3,049,718 | $71,760 | $6,637,307 |
Jakob Dupont, M.D. | 2020 | $319,231 | $143,346 | $443,075 | $1,757,296 | $133,297 | $2,796,245 |
Utpal Koppikar | 2020 | $460,947 | $187,032 | $885,431 | $597,073 | $7,470 | $2,137,953 |
Utpal Koppikar | 2019 | $439,875 | $155,606 | $1,034,714 | $909,080 | $895 | $2,540,170 |
Utpal Koppikar | 2018 | $240,289 | $189,771 | $1,903,500 | $1,886,325 | $398 | $4,220,282 |
Joseph Newell | 2020 | $466,055 | $203,435 | $1,033,965 | $566,713 | $895 | $2,251,063 |
Joseph Newell | 2019 | $390,000 | $155,208 | $1,240,675 | $932,390 | $895 | $2,719,167 |
Joseph Newell | 2018 | $365,000 | $155,490 | $895,000 | $1,060,710 | $16,092 | $2,492,292 |
Kristin Yarema, Ph.D. | 2020 | $368,308 | $147,995 | $668,250 | $1,067,484 | $184,370 | $2,436,407 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1604464/000156459021020128/atra-def14a_20210608.htm
What are Atara Biotherapeutics, Inc's Past Insider Trades?
Atara Biotherapeutics, Inc's most recent insider trade came on May 18, 2023 by Amar Murugan who sold 8,389 units worth $17.09K . In the last 9 years, insiders at Atara Biotherapeutics, Inc have sold an estimated value of $73.52M and bought an estimated value of $10.47M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Isaac E Ciechanover, Chief Executive Officer, Christopher Haqq, EVP, and Joe Newell, Chief Operations Officer .
Atara Biotherapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |